Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel CLL/HCL/SLL Basic Test
Comprehensive Leukemia Diagnosis Through Advanced Flow Cytometry
Immunophenotyping by Flow Cytometry represents a cornerstone in modern hematologic diagnostics, providing unparalleled precision in identifying and classifying lymphoid malignancies. This sophisticated diagnostic approach enables healthcare providers to distinguish between various types of chronic lymphoproliferative disorders with exceptional accuracy. The CLL/HCL/SLL Basic Panel specifically targets three critical lymphoid malignancies that often present diagnostic challenges due to their overlapping clinical features.
What This Advanced Diagnostic Test Measures
Our specialized flow cytometry panel meticulously analyzes multiple cell surface markers to provide comprehensive immunophenotypic profiling:
- B-cell lineage markers including CD19, CD20, and CD79a for B-cell identification
- Maturation and activation markers such as CD5, CD10, and CD23 for differentiation assessment
- Surface immunoglobulin expression patterns including kappa and lambda light chains
- Additional characterization markers like CD11c, CD25, CD103, and FMC7 for specific subtype identification
- Cell population analysis to determine clonality and abnormal cell percentages
Who Should Consider This Diagnostic Panel?
This comprehensive leukemia diagnostic panel is recommended for individuals presenting with:
- Unexplained persistent lymphocytosis with elevated lymphocyte counts
- Enlarged lymph nodes without clear infectious cause
- Splenomegaly or hepatomegaly of unknown origin
- Abnormal complete blood count results suggesting lymphoid malignancy
- Fatigue, night sweats, or unexplained weight loss with hematologic abnormalities
- Previous diagnosis requiring confirmation or subclassification of lymphoid disorder
Clinical Indications and Symptom Presentation
Patients experiencing persistent symptoms such as recurrent infections, easy bruising, or palpable lymphadenopathy should discuss this testing with their hematologist or oncologist. The panel is particularly valuable when routine blood tests reveal atypical lymphocyte morphology or when there’s clinical suspicion of chronic lymphoproliferative disorders.
Significant Benefits of Advanced Immunophenotyping
- Precise Diagnosis: Differentiates between CLL, HCL, and SLL with high specificity
- Treatment Guidance: Provides critical information for targeted therapy selection
- Prognostic Insights: Helps determine disease aggressiveness and expected clinical course
- Monitoring Capability: Enables tracking of treatment response and disease progression
- Rapid Results: Same-day reporting facilitates timely clinical decision-making
- Comprehensive Analysis: Multiple marker assessment reduces diagnostic uncertainty
Understanding Your Test Results
Your immunophenotyping results will provide detailed information about the immunologic characteristics of your lymphocyte populations:
Interpretation Guidelines
- CLL Pattern: Typically shows CD5+, CD23+, weak surface immunoglobulin expression
- HCL Pattern: Characterized by CD11c+, CD25+, CD103+ expression with strong surface markers
- SLL Pattern: Similar to CLL but may show tissue-based presentation differences
- Normal Findings: Polyclonal B-cell population with appropriate maturation markers
- Abnormal Results: Monoclonal populations or aberrant marker expression patterns
Important: All results should be interpreted by your hematologist or oncologist in the context of your complete clinical picture, including physical examination findings, additional laboratory tests, and imaging studies when appropriate.
Test Pricing and Availability
| Test Description | Price Type | Amount (USD) |
|---|---|---|
| Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel CLL/HCL/SLL Basic Test | Discount Price | $312 |
| Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel CLL/HCL/SLL Basic Test | Regular Price | $450 |
Sample Requirements and Processing
Turnaround Time: Sample Daily by 9 AM; Report Same Day
Sample Type: 3 mL (2 mL min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 mL (1 mL min.) Bone Marrow in 1 Green Top (Sodium heparin) tube AND Aspirate Smear
Shipping Instructions: Ship immediately at 18-22°C. DO NOT REFRIGERATE OR FREEZE. Clinical history is mandatory.
Nationwide Accessibility and Convenient Testing
We maintain comprehensive testing facilities across the United States, with specialized flow cytometry laboratories in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures that patients and healthcare providers have access to this advanced diagnostic technology regardless of location.
Why Choose Our Diagnostic Services?
- Board-certified hematopathologists and technical specialists
- State-of-the-art flow cytometry instrumentation
- Rigorous quality control and validation protocols
- Comprehensive clinical correlation services
- Direct communication with referring physicians
- Seamless electronic result delivery
Take Action for Your Health Today
Don’t let diagnostic uncertainty delay your treatment journey. Our Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel provides the clarity needed for effective management of lymphoid malignancies. With same-day results and comprehensive analysis, you can move forward with confidence in your diagnostic pathway.
Ready to schedule your test? Contact our specialized team today to discuss your testing needs and arrange sample collection. Call or WhatsApp us at +1(267) 388-9828 to book your appointment or speak with our clinical specialists about this advanced diagnostic panel.
Take the first step toward precise diagnosis and targeted treatment planning. Our experienced team is ready to support you through every stage of the diagnostic process, from initial consultation to result interpretation and clinical follow-up.
